BSEAGM/EGMResults3h ago
Concord Biotech Ltd
The 41st Annual General Meeting Meeting of the Members of the Company was held on Friday July, 31, 2026 at 12:00 Noon through VC/OAVM. The summary of the proceedings are published herewith.
Concord Biotech Ltd held its 41st Annual General Meeting on July 31, 2026, through video conferencing. The meeting was attended by 38 members, and the requisite quorum was present. The Chairman and Managing Director, Mr. Sudhir Vaid, addressed the shareholders and gave an overview of the company's operations and financial performance for the year ended March 31, 2026. The meeting was conducted in accordance with the provisions of the Companies Act, 2013, and the Statutory Auditors' Report and the Secretarial Audit Report did not contain any qualification, reservation, adverse remark, or disclaimer.
BSEResultResults4h ago
Concord Biotech Ltd
Unaudited Standalone and Consolidated Financial Results for the first quarter ended on June 30, 2026
Concord Biotech Ltd has announced its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026. The results were approved by the Board of Directors, and a Limited Review Report was issued by M/s. BSR & Co. LLP, the Statutory Auditors. The report highlights that the company's financial results are in compliance with Indian Accounting Standard 34 and other accounting principles generally accepted in India.
BSEBoard MeetingResults4h ago
Concord Biotech Ltd
We would like to inform you that the Board of Directors of the Company, at its meeting held today i.e. Friday, July 31, 2026, on review and recommendation of Audit Committee of the Company, ....
Concord Biotech Ltd has announced its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026, with the Board of Directors approving the results at its meeting held on July 31, 2026.
BSECompany UpdateResults3d ago
Concord Biotech Ltd
Pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015, as amended from time to time, read with Para A of Schedule III thereto, We wish to inform you that the Company has arranged ....
Concord Biotech Ltd has arranged an earnings call to discuss its unaudited standalone and consolidated financial results for the first quarter ended June 30, 2026, scheduled on August 3, 2026.
BSEBoard MeetingResults3d ago
Concord Biotech Ltd
Concord Biotech Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 ,inter alia, to consider and approve the unaudited Standalone and ....
Concord Biotech Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 to consider and approve the unaudited Standalone and Consolidated Financial Results for the first quarter ended on June 30, 2026 along with Limited Review Report thereon.